The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Journal: Evidence-based Cardiology. 2011;(4): 33‑38

Read: 8418 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

. Evidence-based Cardiology. 2011;(4):33‑38. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Close metadata

References:

  1. et al. Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet 2010;376:1670-1681.
  2. Amarenco P., Bogousslavsky J., Callahan A. 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-559.
  3. Ridker P.M., Danielson E., Fonseca F.A., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207.
  4. Rordorf G., McDonald C. Spontaneous intracerebral hemorrhage: pathogenesis, clinical features, and diagnosis. In: Kasner S.E., Wilterdink J.L., eds. UpToDate, Version 18.2. Waltham, MA: UpToDate Inc; 2010.
  5. Kokotailo R.A., Hill M.D. Coding of stroke and stroke risk factors using International Classification of Diseases, revisions 9 and 10. Stroke 2005;36:1776-1781.
  6. Downs S.H., Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and nonrandomized studies of health care interventions. J Epidemiol Community Health 1998;52:377-384.
  7. Fellstrom B.C., Jardine A.G., Schmieder R.E., et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009;360:1395-1407.
  8. Tavazzi L., Maggioni A.P., Marchioli R., et al. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:1231-1239.
  9. Kjekshus J., Apetrei E., Barrios V., et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007;357:2248-2261.
  10. Nakamura H., Arakawa K., Itakura H., et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 2006;368:1155-1163.
  11. Wanner C., Krane V., Marz W., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353:238-248.
  12. Holdaas H., Fellstrom B., Jardine A.G., et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 2003;361:2024-2031.
  13. Sever P., Dahlof B., Poulter N.R., et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-1158.
  14. et al. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 2002;288:2998-3007.
  15. Shepherd J., Blauw G.J., Murphy M.B., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360:1623-1630.
  16. et al. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
  17. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285:1711-1718.
  18. et al. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: the Long-Term Intervention With Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998;339:1349-1357.
  19. Downs J.R., Clearfield M., Weis S., et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS: Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615-1622.
  20. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996;335:1001-1009.
  21. Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study
  22. et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
  23. Furberg C.D., Adams H.P. Jr, Applegate W.B., et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events: Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 1994;90:1679-1687.
  24. Knopp R.H., d'Emden M., Smilde J.G., Pocock S.J. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). Diabetes Care 2006;29:1478-1485.
  25. Athyros V.G., Papageorgiou A.A., Mercouris B.R., et al. Treatment with atorvastatin to the National Cholesterol Educational Program goal versus "usual" care in secondary coronary heart disease prevention: the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Curr Med Res Opin 2002;18:220-228.
  26. Bone H.G., Kiel D.P., Lindsay R.S., et al. Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial. J Clin Endocrinol Metab 2007;92:4671-4677.
  27. Kleemann A., Eckert S., von Eckardstein A., et al. Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA: the Cholesterol Lowering Atherosclerosis PTCA Trial (CLAPT). Eur Heart J 1999;20:1393-1406.
  28. et al. Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico). Ital Heart J 2000;1:810-820.
  29. Bhatt D.L., Fox K.A.A., Hacke W., et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-1717.
  30. Arima H., Tzourio C., Butcher K., et al. Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial. Stroke 2006;37:1497-1502.
  31. Bushnell C.D., Newby L.K., Goldstein L.B., et al. Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). Neurology 2004;62:968-970.
  32. Bushnell C.D., Griffin J., Newby L.K., et al. Statin use and sex-specific stroke outcomes in patients with vascular disease. Stroke 2006;37:1427-1431.
  33. Capampangan D.J., Pearce L.A., Asbury K.L., et al. Lipid profile and statin use in ischemic stroke and intracerebral hemorrhage [abstract]. J Neurol Sci 2009;285:S73.
  34. Chang C.H., Shau W.Y., Kuo C.W., et al. Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study. Stroke 2010;41:1884-1890.
  35. Chen P.S., Li Y.H., Chang C.L., Kao Yang Y.H. Early statin therapy improves clinical outcomes than delayed statin treatment in patients with acute ischemic stroke [abstract]. Circulation 2010;122:A13376.
  36. Douketis J.D., Melo M., Bell C.M., Mamdani M.M. Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin? Am J Med 2007;120:369.e9-369.e14.
  37. Simon T., Steg P.G., Gilard M., et al. Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Registry. Circulation 2011;123:474-482.
  38. FitzMaurice E., Wendell L., Snider R., et al. Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke 2008;39:2151-2154.
  39. Gregoire S.M., Jager H.R., Yousry T.A., et al. Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage: hospital-based, case-control study. J Neurol Neurosurg Psychiatry 2010;81:679-684.
  40. Kennedy J., Quan H., Buchan A.M., et al. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 2005;36:2072-2076.
  41. Sasaki J, Arakawa K, Iwashita M, et al. Reduction in serum total cholesterol and risks of coronary events and cerebral infarction in Japanese men: the Kyushu Lipid Intervention Study. Circ J 2003;67:473-478.
  42. Tirschwell D.L., Smith N.L., Heckbert S.R., et al. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 2004;63:1868-1875.
  43. Verdel B.M., Souverein P.C., Meenks S.D., et al. Use of serotonergic drugs and the risk of bleeding. Clin Pharmacol Ther 2011;89:89-96.
  44. Verzini F., De R.P., Parlani G., et al. Effects of statins on early and late results of carotid stenting. J Vasc Surg 2011;53:71-79.
  45. Woo D., Kissela B.M., Khoury J.C., et al. Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study. Stroke 2004;35:1360-1364.
  46. Hackam D., Austin P., Huang A., et al. Statins and intracerebral hemorrhage: a retrospective cohort study [published online ahead of print September 12, 2011]. Arch Neurol. doi:10.1001/archneurol.2011.228.
  47. Uchiyama S., Ikeda Y., Urano Y., et al. The Japanese Aggrenox (Extended-Release Dipyridamole plus Aspirin) Stroke Prevention versus Aspirin Programme (JASAP) Study: a randomized, double-blind, controlled trial. Cerebrovasc Dis 2011;31:601-613.
  48. Amarenco P., Goldstein L.B., Szarek M., et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial. Stroke 2007;38:3198-3204.
  49. Goldstein L.B., Amarenco P., Szarek M., et al. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 2008;70:2364-2370.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.